Haruko Tashiro

2.2k citations

57 papers · 1.6k indexed · 1 hit paper · h-index 13

Co-authors: Malcolm K. Brenner Maksim Mamonkin Rayne H. Rouce Cliona M. Rooney Bilal OmerHao LiuThomas Shum Stephen Gottschalk
Topics: CAR-T cell therapy research (20 papers)Acute Myeloid Leukemia Research (12 papers)Hematopoietic Stem Cell Transplantation (11 papers)
Cited by: Oncology Immunology Genetics
Journals: The Journal of Experimental MedicineSHILAP Revista de lepidopterologíaBlood
Partner nations: Japan United States Germany

In The Last Decade

Haruko Tashiro

52 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

2017 391 citations Andras Heczey, Chrystal U. Louis et al. Molecular Therapy profile →

Peers

Countries citing papers authored by Haruko Tashiro

Since Specialization

Citations

This map shows the geographic impact of Haruko Tashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Tashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Tashiro more than expected).

Fields of papers citing papers by Haruko Tashiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruko Tashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Tashiro. The network helps show where Haruko Tashiro may publish in the future.

Co-authorship network of co-authors of Haruko Tashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Haruko Tashiro. A scholar is included among the top collaborators of Haruko Tashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruko Tashiro. Haruko Tashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Guillain-Barré syndrome with T-cell receptor gene clonal rearrangement following COVID-19 vaccination: a case report 2025 ·Clinical and Experimental Vaccine Research ·Kensuke Matsumoto,(unknown),Kumiko Tokuda,(unknown),(unknown),Ryosuke Shirasaki,Jun Ooi,Haruko Tashiro	0
2	[CAR T-cell therapy for T cell malignancies: challenges and recent advances]. 2024 ·PubMed ·Haruko Tashiro	1
3	The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients 2022 ·Leukemia Research ·(unknown),Haruko Tashiro,Ryosuke Shirasaki,(unknown),Tadashi Yamamoto,Kensuke Matsumoto,Jun Ooi,Naoki Shirafuji	2
4	Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia 2022 ·Transplantation and Cellular Therapy ·Masamitsu Yanada,(unknown),(unknown),Takahiro Fukuda,Kazutaka Ozeki,Shuichi Ota,Haruko Tashiro,Naoyuki Uchida,Shinichi Kako,Noriko Doki,Toshiro Kawakita,Yasushi Onishi,Satoru Takada,Yukio Kondo,Junji Tanaka,Yoshinobu Kanda,Yoshiko Atsuta,Shingo Yano	5
5	Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia 2021 ·Clinical & Translational Immunology ·Aiko Hasegawa,Shoji Saito,(unknown),Shigeru Nakano,(unknown),Hideki Ohnota,Yoichi Inada,(unknown),(unknown),(unknown),(unknown),Kazuyuki Matsuda,Haruko Tashiro,Shigeki Yagyu,Miyuki Tanaka,Yozo Nakazawa	21
6	Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors 2021 ·Medicine ·(unknown),Haruko Tashiro,(unknown),(unknown),Tadashi Yamamoto,Kensuke Matsumoto,Jun Ooi,Naoki Shirafuji	2
7	The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse 2020 ·International Journal of Hematology ·Saiko Kurosawa,Hiroki Yamaguchi,Takuhiro Yamaguchi,Keiko Fukunaga,Shunsuke Yui,Heiwa Kanamori,Kensuke Usuki,Nobuhiko Uoshima,Masamitsu Yanada,Jin Takeuchi,Ishikazu Mizuno,Junya Kanda,Hiroshi Okamura,Shingo Yano,Haruko Tashiro,Takero Shindo,Shigeru Chiba,Junji Tomiyama,Koiti Inokuchi,Takahiro Fukuda	10
8	Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells 2018 ·Frontiers in Medicine ·Bilal Omer,Paul Castillo,Haruko Tashiro,Thomas Shum,(unknown),(unknown),Miyuki Tanaka,(unknown),Tim Sauer,Robin Parihar,Natalia Lapteva,Michael Schmueck‐Henneresse,Malini Mukherjee,Stephen Gottschalk,Cliona M. Rooney	15
9	Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells 2017 ·Cancer Discovery ·Thomas Shum,Bilal Omer,Haruko Tashiro,Robert L. Kruse,Dimitrios L. Wagner,Kathan Parikh,Zhongzhen Yi,Tim Sauer,Daofeng Liu,Robin Parihar,Paul Castillo,Hao Liu,Malcolm K. Brenner,Leonid S. Metelitsa,Stephen Gottschalk,Cliona M. Rooney	220
10	Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells 2017 ·Clinical Cancer Research ·Miyuki Tanaka,Haruko Tashiro,Bilal Omer,(unknown),Jun Ando,Minhtran Ngo,Birju Mehta,Gianpietro Dotti,Paul R. Kinchington,Ann M. Leen,Claudia Rössig,Cliona M. Rooney	81
11	Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia 2017 ·Blood ·Diogo Gomes‐Silva,Haruko Tashiro,Madhuwanti Srinivasan,Premal Lulla,Malcolm K. Brenner,Maksim Mamonkin	2
12	Low High-Density Lipoprotein Cholesterol (HDL) Is a Significant Poor Prognostic Factor in Malignant Lymphoma 2017 ·Blood ·(unknown),Haruko Tashiro,(unknown),Tadashi Yamamoto,(unknown),Kensuke Matsumoto,Jun Ooi,Naoki Shirafuji	2
13	Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1 2017 ·Molecular Therapy ·Haruko Tashiro,Tim Sauer,Thomas Shum,Kathan Parikh,Maksim Mamonkin,Bilal Omer,Rayne H. Rouce,Premal Lulla,Cliona M. Rooney,Stephen Gottschalk,Malcolm K. Brenner	116
14	CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastomabreakdown → 2017 ·Molecular Therapy ·Andras Heczey,Chrystal U. Louis,Barbara Savoldo,Olga Dakhova,April Durett,Bambi Grilley,Hao Liu,(unknown),Zhuyong Mei,Adrian P. Gee,Birju Mehta,Huimin Zhang,Nadia Mahmood,Haruko Tashiro,Helen E. Heslop,Gianpietro Dotti,Cliona M. Rooney,Malcolm K. Brenner	391
15	Immunotherapy against cancer-related viruses 2016 ·Cell Research ·Haruko Tashiro,Malcolm K. Brenner	103
16	Hyperuricemia in Hematologic Malignancies Is Caused by an Insufficient Urinary Excretion 2014 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown),Haruko Tashiro,(unknown),Tadashi Yamamoto,Nobu Akiyama,Kazuo Kawasugi,Naoki Shirafuji,Shin Fujimori	11
17	Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19) 2011 ·International Journal of Hematology ·Ryosuke Shirasaki,Haruko Tashiro,(unknown),(unknown),Tadashi Yamamoto,(unknown),Nobu Akiyama,Kazuo Kawasugi,Naoki Shirafuji	3
18	Autoimmune neutropenia due to antineutrophil antibodies in a patient with primary sclerosing cholangitis 2010 ·Clinical Journal of Gastroenterology ·Naoko Hanawa,Atsushi Tanaka,(unknown),Ryo Miura,Hideaki Goto,Haruko Tashiro,(unknown),Yoriyuki Takamori,Yoshiyuki Fujita,Takashi Sato,Hiroshi Kawaguchi,Masao Kobayashi,Hajime Takikawa	1
19	Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART 2009 ·International Journal of Hematology ·(unknown),Haruko Tashiro,(unknown),(unknown),(unknown),Ryosuke Shirasaki,Toshiyuki Miura,Nobu Akiyama,Kazuo Kawasugi,Shin Fujimori,Naoki Shirafuji	3
20	Acute myelogenous leukemia cells with the MLL–ELL translocation convert morphologically and functionally into adherent myofibroblasts 2009 ·Biochemical and Biophysical Research Communications ·Haruko Tashiro,(unknown),Ryosuke Shirasaki,Naoki Shirafuji	6

About Haruko Tashiro

Haruko Tashiro is a scholar working on Hematology, Oncology and Genetics, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (536 citations) and Genetics (449 citations). Haruko Tashiro has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Malcolm K. Brenner, Maksim Mamonkin, Rayne H. Rouce, Cliona M. Rooney, Bilal Omer, Hao Liu, Thomas Shum, Stephen Gottschalk, Gianpietro Dotti and Birju Mehta. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact